Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. (Q30437778)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. |
scientific article |
Statements
1 reference
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177. (English)
1 reference
Bernd W Scheithauer
1 reference
Paul D Brown
1 reference
Sunil Krishnan
1 reference
Jann N Sarkaria
1 reference
Wenting Wu
1 reference
Kurt A Jaeckle
1 reference
Joon H Uhm
1 reference
Francois J Geoffroy
1 reference
Robert Arusell
1 reference
Gaspar Kitange
1 reference
Robert B Jenkins
1 reference
John W Kugler
1 reference
Roscoe F Morton
1 reference
Kendrith M Rowland
1 reference
Paul Mischel
1 reference
William H Yong
1 reference
David Schiff
1 reference
Caterina Giannini
1 reference
Jan C Buckner
1 reference
North Central Cancer Treatment Group Study N0177
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference